Physician profile
Andrew Tang
NPI 1811383250
$4,228.71
in general payments reported to CMS, 2019-2025
20 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $294 · 2021: $78.22 · 2022: $396 · 2023: $1,530 · 2024: $338 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,242.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $778.52 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Corcym INC | $709.02 | 2023-2025 | Perceval, Memo 4d |
| Edwards Lifesciences Corporation | $625.74 | 2023-2025 | Inspiris Resilia Aortic Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Davol INC. | $603.26 | 2019-2023 | Progel Applicator Spray Tips |
| Abbott Laboratories | $369.61 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Ethicon US, LLC | $233.01 | 2020-2024 | Echelon Endopath, Ethicon |
| Medtronic, INC. | $172.88 | 2023-2025 | Corevalve Evolut R, Accuvac |
| Bolton Medical INC | $147.84 | 2022 | |
| Baxter Healthcare | $116.06 | 2023 | Coseal |
| Becton, Dickinson and Company | $98.40 | 2023 | Phasix Mesh |
| Medical Device Business Services, INC. | $78.22 | 2021 | |
| Teleflex LLC | $77.23 | 2024 | Quikclot |
| Abiomed | $62.48 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.61 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.88 | 2019-2020 | |
| Kls-Martin L.P. | $22.40 | 2025 | |
| Glaxosmithkline, LLC. | $18.70 | 2020 | |
| Pfizer INC. | $16.84 | 2019 | |
| Merck Sharp & Dohme LLC | $14.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.